Daniel Grosslight

Q: What is Daniel Grosslight's success rate?

Daniel Grosslight currently has a success rate of 92.88913076133751.

Q: What is the average return of Daniel Grosslight's calls?

Their stock ratings have generated an average return of 30.76121816859016.

Citigroup | Healthcare

Daniel Grosslight is an analyst from Citigroup specializing in the Healthcare sector. Ranked #519 out of 4739 analysts, they have issued 56 stock ratings with a success rate of 92.89% and an average return of 30.76%.

Daniel Grosslight has a well-established track record, with 56 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 92.89% and an average return of 30.76%, underscoring their expertise and ability to identify winning opportunities for investors.

#519

Out of 4739

Total Ratings

+92.89%

Success Rate

+30.76%

Average Return

Recent Ratings Analysis

EVH

Hold

Jul 23, 2026

Target

$6.75

Current

$5.57

Performance

—

Daniel Grosslight rated EVH as Neutral on Jul 23, 2026, setting a price target of 6.75. The Hold stance appears justified, as shares hovered around 5.57 with a % move.

AGL

Sell

Jul 23, 2026

Target

$105.00

Current

$119.88

Performance

—

On Jul 23, 2026, AGL was given a Sell rating by Daniel Grosslight, with a target price of 105. The stock traded sideways with only a % move, leaving the Sell case unresolved.

GMRS

Buy

Jun 08, 2026

Target

$17.00

Current

$12.80

Performance

20.98%

GMRS received a Buy rating from Daniel Grosslight on Jun 08, 2026, aiming for 17. Momentum has favored the Buy call, with shares climbing from 12.8 to 12.8, rewarding those who trusted the recommendation.

PHR

Hold

May 28, 2026

Target

$12.00

Current

$10.01

Performance

5.93%

On May 28, 2026, Daniel Grosslight published a Neutral outlook on PHR, with a target of 12. The Hold call missed some of the bullish momentum as shares advanced toward 12.

ZTS

Buy

May 18, 2026

Target

$112.00

Current

$74.17

Performance

-4.57%

Daniel Grosslight on May 18, 2026 assigned ZTS a Buy rating, with a price target of 112. The recommendation remains pending validation as shares consolidate around 74.17.

PAHC

Hold

May 14, 2026

Target

$44.00

Current

$33.81

Performance

-6.47%

On May 14, 2026, Daniel Grosslight reaffirmed PAHC with a Neutral rating, targeting 44. The Hold stance reflected market caution that was later justified.

MCK

Buy

May 14, 2026

Target

$945.00

Current

$814.04

Performance

8.94%

MCK was rated Buy by Daniel Grosslight on May 14, 2026, with a price objective of 945. A bullish response from the market helped close the gap of 130.96 to the target.

GDRX

Buy

May 14, 2026

Target

$4.00

Current

$2.93

Performance

17.67%

On May 14, 2026, Daniel Grosslight initiated coverage on GDRX with a Buy rating and target of 4. The stock’s climb of 17.67% since the call highlights the foresight in the rating.

HIMS

Hold

May 12, 2026

Target

$28.00

Current

$31.68

Performance

26.57%

Daniel Grosslight issued a Neutral recommendation for HIMS on May 12, 2026, price target set at 28. A neutral call gave way to stronger-than-expected performance, closing in on 28.

ACH

Buy

May 12, 2026

Target

$5.00

Current

$3.16

Performance

-1.25%

On May 12, 2026, ACH was evaluated by Daniel Grosslight, who gave a Buy rating and target of 5. So far, the Buy call awaits clearer momentum, with shares flat at 3.16.

COR

Buy

May 07, 2026

Target

$355.00

Current

$300.58

Performance

17.57%

Daniel Grosslight rated COR as Buy on May 07, 2026, setting a price target of 355. The call has proven timely, with shares rising 17.57% toward the price target of 355.

ELAN

Buy

May 07, 2026

Target

$31.00

Current

$25.34

Performance

5.54%

On May 07, 2026, ELAN was given a Buy rating by Daniel Grosslight, with a target price of 31. The stock rallied 5.54% after the rating, narrowing the gap to the target of 31 and validating the bullish stance.

WAY

Buy

May 05, 2026

Target

$30.00

Current

$20.79

Performance

0.82%

WAY received a Buy rating from Daniel Grosslight on May 05, 2026, aiming for 30. Price action was muted, as shares hovered around 20.79 despite the bullish outlook.

TDOC

Hold

May 05, 2026

Target

$7.00

Current

$8.92

Performance

33.93%

On May 05, 2026, Daniel Grosslight published a Neutral outlook on TDOC, with a target of 7. The Hold call missed some of the bullish momentum as shares advanced toward 7.

CAH

Buy

May 01, 2026

Target

$245.00

Current

$220.54

Performance

—

Daniel Grosslight on May 01, 2026 assigned CAH a Buy rating, with a price target of 245. The recommendation remains pending validation as shares consolidate around 220.54.

XRAY

Sell

Apr 15, 2026

Target

$10.00

Current

$13.27

Performance

—

On Apr 15, 2026, Daniel Grosslight reaffirmed XRAY with a Sell rating, targeting 10. Price action has been neutral, giving no verdict on the Sell call.

NVST

Hold

Apr 15, 2026

Target

$29.00

Current

$26.43

Performance

—

NVST was rated Neutral by Daniel Grosslight on Apr 15, 2026, with a price objective of 29. Flat performance suggests the Hold view was reasonable.

ALGN

Buy

Apr 15, 2026

Target

$240.00

Current

$172.46

Performance

—

On Apr 15, 2026, Daniel Grosslight initiated coverage on ALGN with a Buy rating and target of 240. Neutral price movement of % leaves room for interpretation.

IDXX

Hold

Apr 15, 2026

Target

$650.00

Current

$545.00

Performance

—

Daniel Grosslight issued a Neutral recommendation for IDXX on Apr 15, 2026, price target set at 650. The rating was appropriate for a consolidating market trading near 545.

HSIC

Buy

Apr 15, 2026

Target

$100.00

Current

$84.81

Performance

—

On Apr 15, 2026, HSIC was evaluated by Daniel Grosslight, who gave a Buy rating and target of 100. So far, the Buy call awaits clearer momentum, with shares flat at 84.81.

HCAT

Hold

Mar 13, 2026

Target

$1.75

Current

$2.04

Performance

54.55%

Daniel Grosslight rated HCAT as Neutral on Mar 13, 2026, setting a price target of 1.75. Despite the Hold call, shares climbed 54.55% to 2.04, revealing unexpected momentum.

PRVA

Buy

Mar 03, 2026

Target

$34.00

Current

$25.37

Performance

6.73%

On Mar 03, 2026, PRVA was given a Buy rating by Daniel Grosslight, with a target price of 34. The stock rallied 6.73% after the rating, narrowing the gap to the target of 34 and validating the bullish stance.

CTEV

Buy

Feb 25, 2026

Target

$63.00

Current

$24.98

Performance

68.56%

CTEV received a Buy rating from Daniel Grosslight on Feb 25, 2026, aiming for 63. Momentum has favored the Buy call, with shares climbing from 24.98 to 24.98, rewarding those who trusted the recommendation.

OMI

Buy

Aug 12, 2025

Target

$7.00

Current

$2.68

Performance

-51.01%

On Aug 12, 2025, Daniel Grosslight published a Buy outlook on OMI, with a target of 7. Market action contradicted the Buy thesis, as shares slipped to 2.68.

MPLN

Hold

Jan 10, 2025

Target

$12.50

Current

$23.15

Performance

81.85%

Daniel Grosslight on Jan 10, 2025 assigned MPLN a Neutral rating, with a price target of 12.5. Shares outperformed expectations, climbing 81.85% despite the neutral view.

Frequency Asked Questions

Who is Daniel Grosslight?

Daniel Grosslight is an analyst from Citigroup specializing in the Healthcare sector.

What is Daniel Grosslight's success rate?

Daniel Grosslight currently has a success rate of +92.89%.

How many ratings has Daniel Grosslight issued?

Daniel Grosslight has issued 56 stock ratings so far.

What is the average return of Daniel Grosslight's calls?

Their stock ratings have generated an average return of +30.76%.

What is Daniel Grosslight's ranking?

Daniel Grosslight is ranked #519 out of 4739 analysts.

What types of ratings does Daniel Grosslight give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Daniel Grosslight?

You can follow Daniel Grosslight by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Daniel Grosslight?

Their latest rating was a Hold on EVH issued on 2026-07-23.